In conclusion, the findings suggest that proBDNF, BDNF, and IL-18 are linked to clinical symptoms of MDD, and that TNF-α and IL-6 have the potential to serve as objective biomarkers for the diagnosis of MDD. The gene discussed is IL18; the disease is major depressive disorder.